ÁñÁ«ÊÓƵ

This cohort study investigates if there is an increased risk of symptomatic intracerebral hemorrhage associated with prestroke antiplatelet therapy after treatment in intravenous alteplase.

This cohort study evaluates recent reversals in declines in cardiovascular mortality and whether they vary across sociodemographic categories.

This cohort study evaluates whether door-to-treatment time is associated with outcome among patients with anticoagulation-associated intracerebral hemorrhage treated with reversal interventions.

This study performs a systematic review to identify which types of system-level initiatives are most effective at improving guideline-directed medical therapy use among patients with heart failure with reduced ejection fraction.

This quality improvement study investigates the thrombolysis metrics and outcomes associated with the Target: Stroke initiative by race and ethnicity in a national cohort of US hospitals.

This cross-sectional study examines outcomes for patients hospitalized with heart failure to compare changes in the quality and outcomes of care according to hospital participation in the Medicare Bundled Payments for Care Improvement program.

This cohort study investigates the prevalence and overlap of cardiac, renal, and metabolic conditions in US adults, using data from the National Health and Nutrition Examination Survey.

This economic evaluation examines the cost-effectiveness of sacubitril-valsartan among a range of ejection fractions and at different upper-level cutoffs of below-normal ejection fractions.

This retrospective cohort study assesses the association between recent use of oral vitamin K antagonists and symptomatic intracranial hemorrhage among patients with acute ischemic stroke undergoing endovascular thrombectomy.

This cohort study characterizes patterns of sodium-glucose cotransporter-2 inhibitor use among eligible patients hospitalized for heart failure with reduced ejection fraction (HFrEF).

This cross-sectional study compares quality and outcomes for heart failure at hospitals with high proportions of Black patients vs other hospitals.

This economic evaluation investigates if the addition of a sodium-glucose cotransporter-2 inhibitor to standard therapy would be cost-effective in individuals with heart failure and preserved ejection fraction.

This cohort study assesses quality of care and clinical outcomes for US patients hospitalized for heart failure at rural vs urban hospitals in the Get With The Guidelines–Heart Failure registry.

This cohort study compares oral anticoagulation use at discharge and atrial fibrillation–related outcomes by race and ethnicity in the Get With The Guidelines–Atrial Fibrillation registry.

This decision analytical model study quantifies the estimated US population-level impact of reducing heart failure events with sodium-glucose cotransporter-2 inhibitors in left ventricular ejection fraction more than 40%.

This cohort study of data on participants in the Cardiovascular Health Study assesses risk of lung cancer in smokers for whom low-density computed tomographic screening is not recommended.

This cohort study used data from the American Heart Association/American Stroke Association Get With The Guidelines–Stroke registry to assess prescribing patterns for dual antiplatelet therapy at discharge among patients with minor and nonminor acute ischemic stroke.